PROfound: PARP inhibitor olaparib compared with new hormonal agents in advanced ...
Prof Maha Hussain - Northwestern University Feinberg School of Medicine, Chicago...
PROfound: PARP inhibitor olaparib compared with new hormonal agents in advanced castration resistant prostate cancer ( Prof Maha Hussain - Northwestern University Feinberg School of Medicine, Chicago, USA )
7 Nov 2019
Using aspirin for colorectal cancer prevention
Prof Paola Patrignani - University of Chieti, Chieti and Pescara, Italy
Using aspirin for colorectal cancer prevention ( Prof Paola Patrignani - University of Chieti, Chieti and Pescara, Italy )
24 Oct 2019
Using aspirin for cancer prevention
Prof Ruth Langley - University College London, London, UK
Using aspirin for cancer prevention ( Prof Ruth Langley - University College London, London, UK )
24 Oct 2019
The treatment landscape of occular melanoma
Maitry Patel CCPA - Princess Margaret Cancer Centre, Toronto, Canada
The treatment landscape of occular melanoma ( Maitry Patel CCPA - Princess Margaret Cancer Centre, Toronto, Canada )
21 Oct 2019
Rectal cancer in Latin America, screening and surgery
Dr. Nitin Mishra - Mayo Clinic, Rochester, USA
Rectal cancer in Latin America, screening and surgery ( Dr. Nitin Mishra - Mayo Clinic, Rochester, USA )
21 Oct 2019
Pain and symptom management in palliative care
Judy Knudson, PA-C - University of Colorado, Denver, USA
Pain and symptom management in palliative care ( Judy Knudson, PA-C - University of Colorado, Denver, USA )
17 Oct 2019
The role of the pharmacist in supporting multi-disciplinary education
Niels Boone - Zuyderland Medical Center, Heerlen, Netherlands
The role of the pharmacist in supporting multi-disciplinary education ( Niels Boone - Zuyderland Medical Center, Heerlen, Netherlands )
8 Oct 2019
Effective communication about biosimilars
Niels Boone - Zuyderland Medical Center, Heerlen, Netherlands
Effective communication about biosimilars ( Niels Boone - Zuyderland Medical Center, Heerlen, Netherlands )
8 Oct 2019
Assessing biosimilars in the real world setting
Niels Boone - Zuyderland Medical Center, Heerlen, Netherlands
Assessing biosimilars in the real world setting ( Niels Boone - Zuyderland Medical Center, Heerlen, Netherlands )
8 Oct 2019
Realising the potential of biosimilars
Prof Arnold Vulto - Erasmus University Rotterdam, Rotterdam, Netherlands
Realising the potential of biosimilars ( Prof Arnold Vulto - Erasmus University Rotterdam, Rotterdam, Netherlands )
8 Oct 2019
Comment: Supporting a sustainable biosimilar solution
Prof Arnold Vulto - Erasmus University Rotterdam, Rotterdam, Netherlands
Comment: Supporting a sustainable biosimilar solution ( Prof Arnold Vulto - Erasmus University Rotterdam, Rotterdam, Netherlands )
8 Oct 2019
Comment: Use of biosimilar monoclonal antibodies in the clinic
Prof Arnold Vulto - Erasmus University Rotterdam, Rotterdam, Netherlands
Comment: Use of biosimilar monoclonal antibodies in the clinic ( Prof Arnold Vulto - Erasmus University Rotterdam, Rotterdam, Netherlands )
8 Oct 2019